Localization of PPARδ in murine central nervous system: Expression in oligodendrocytes and neurons

Brain Research

Volumn 975, Issue 1-2, 2003, Pages 10-21

  Woods, John W ^a   Tanen, Michael ^b   Figueroa, David J ^a   Biswas, Chhabi ^b   Zycband, Emanuel ^a   Moller, David E ^b   Austin, Christopher P ^a   Berger, Joel P ^a,b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b Department of Metabolic Disorders ^*  (United States)

Author keywords

Brain; CNS; Immunolocalization; Peroxisome proliferator activated receptors

Indexed keywords

MESSENGER RNA; PEPTIDE ANTIBODY; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; CELL RECEPTOR; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN NERVE CELL; CAUDATE NUCLEUS; CELL TYPE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CORPUS CALLOSUM; ENTORHINAL CORTEX; HIPPOCAMPUS; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PUTAMEN; RNA PROBE; TISSUE DISTRIBUTION; ANIMAL; ANTIBODY PRODUCTION; BIOSYNTHESIS; BRAIN LEVEL; CELL CULTURE; CELL STRAIN COS1; CERCOPITHECUS; CYTOLOGY; DNA PROBE; ENZYME IMMUNOASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC TRANSFECTION; GENETICS; HISTOLOGY; METABOLISM; NERVE CELL; NORTHERN BLOTTING; PHYSIOLOGY; REPRODUCIBILITY; WESTERN BLOTTING;

ANIMALS; ANTIBODY FORMATION; BLOTTING, NORTHERN; BLOTTING, WESTERN; BRAIN CHEMISTRY; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM; CERCOPITHECUS AETHIOPS; COS CELLS; DNA PROBES; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOENZYME TECHNIQUES; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MICE; NEURONS; OLIGODENDROGLIA; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 0037728848     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(03)02515-0     Document Type: Article

References (29)

1. Barak Y., Liao D., He W., Ong E.S., Nelson M.C., Olefsky J.M., Boland R., Evans R.M. Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer. Proc. Natl. Acad. Sci. USA. 99:2002;303-308.
2. Berger J., Moller D.E. The mechanisms of action of PPARs. Annu. Rev. Med. 53:2002;409-435.
3. Berger J., Patel H.V., Woods J., Hayes N.S., Parent S.A., Clemas J., Leibowitz M.D., Elbrecht A., Rachubinski R.A., Capone J.P., Moller D.E. A PPARgamma mutant serves as a dominant negative inhibitor of PPAR signaling and is localized in the nucleus. Mol. Cell. Endocrinol. 162:2000;57-67.
4. Berger T., Reindl M. Immunopathogenic and clinical relevance of antibodies against myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis. J. Neural Transm. Suppl. 1:2000;351-360.
5. Bocher V., Pineda-Torra I., Fruchart J.C., Staels B. PPARs: transcription factors controlling lipid and lipoprotein metabolism. Ann. NY Acad. Sci. 967:2002;7-18.
6. Braissant O., Foufelle F., Scotto C., Dauca M., Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology. 137:1996;354-366.
7. Braissant O., Wahli W. Differential expression of peroxisome proliferator-activated receptor-alpha, -beta, and -gamma during rat embryonic development. Endocrinology. 139:1998;2748-2754.
8. Calabresi P., Pisani A., Mercuri N.B., Bernardi G. The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia. Trends Neurosci. 19:1996;19-24.
9. Cullingford T.E., Bhakoo K., Peuchen S., Dolphin C.T., Patel R., Clark J.B. Distribution of mRNAs encoding the peroxisome proliferator-activated receptor alpha, beta, and gamma and the retinoid X receptor alpha, beta, and gamma in rat central nervous system. J. Neurochem. 70:1998;1366-1375.
10. Elbrecht A., Chen Y., Cullinan C.A., Hayes N., Leibowitz M., Moller D.E., Berger J. Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2. Biochem. Biophys. Res. Commun. 224:1996;431-437.
11. Figueroa D.J., Hess J.F., Ky B., Brown S.D., Sandig V., Hermanowski-Vosatka A., Twells R.C., Todd J.A., Austin C.P. Expression of the type I diabetes-associated gene LRP5 in macrophages, vitamin A system cells, and the Islets of Langerhans suggests multiple potential roles in diabetes. J. Histochem. Cytochem. 48:2000;1357-1368.
12. Granneman J., Skoff R., Yang X. Member of the peroxisome proliferator-activated receptor family of transcription factors is differentially expressed by oligodendrocytes. J. Neurosci. Res. 51:1998;563-573.
13. Gupta R.A., Tan J., Krause W.F., Geraci M.W., Willson T.M., Dey S.K., DuBois R.N. Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer. Proc. Natl. Acad. Sci. USA. 97:2000;13275-13280.
14. He T.C., Chan T.A., Vogelstein B., Kinzler K.W. PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell. 99:1999;335-345.
15. Issemann I., Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature. 347:1990;645-650.
16. Kliewer S.A., Forman B.M., Blumberg B., Ong E.S., Borgmeyer U., Mangelsdorf D.J., Umesono K., Evans R.M. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc. Natl. Acad. Sci. USA. 91:1994;7355-7359.
17. Kliewer S.A., Xu H.E., Lambert M.H., Willson T.M. Peroxisome proliferator-activated receptors: from genes to physiology. Recent Prog. Horm. Res. 56:2001;239-263.
18. Kremarik-Bouillaud P., Schohn H., Dauca M. Regional distribution of PPARbeta in the cerebellum of the rat. J. Chem. Neuroanat. 19:2000;225-232.
19. Leibowitz M.D., Fievet C., Hennuyer N., Peinado-Onsurbe J., Duez H., Berger J., Cullinan C.A., Sparrow C.P., Baffic J., Berger G.D., Santini C., Marquis R.W., Tolman R.L., Smith R.G., Moller D.E., Auwerx J. Activation of PPARdelta alters lipid metabolism in db/db mice. FEBS Lett. 473:2000;333-336.
20. Lemberger T., Braissant O., Juge-Aubry C., Keller H., Saladin R., Staels B., Auwerx J., Burger A.G., Meier C.A., Wahli W. PPAR tissue distribution and interactions with other hormone-signaling pathways. Ann. NY Acad. Sci. 804:1996;231-251.
21. Lim H., Gupta R.A., Ma W.G., Paria B.C., Moller D.E., Morrow J.D., DuBois R.N., Trzaskos J.M., Dey S.K. Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta. Genes Dev. 13:1999;1561-1574.
22. McLean I.W., Nakane P.K. Periodate-lysine-paraformaldehyde fixative. A new fixation for immunoelectron microscopy. J. Histochem. Cytochem. 22:1974;1077-1083.
23. Peters J.M., Lee S.S., Li W., Ward J.M., Gavrilova O., Everett C., Reitman M.L., Hudson L.D., Gonzalez F.J. Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta). Mol. Cell. Biol. 20:2000;5119-5128.
24. Saluja I., Granneman J.G., Skoff R.P. PPAR delta agonists stimulate oligodendrocyte differentiation in tissue culture. Glia. 33:2001;191-204.
25. Schmidt A., Endo N., Rutledge S.J., Vogel R., Shinar D., Rodan G.A. Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids. Mol. Endocrinol. 6:1992;1634-1641.
26. Sher T., Yi H.F., McBride O.W., Gonzalez F.J. cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor. Biochemistry. 32:1993;5598-5604.
27. Shi Y., Hon M., Evans R.M. The peroxisome proliferator-activated receptor delta, an integrator of transcriptional repression and nuclear receptor signaling. Proc. Natl. Acad. Sci. USA. 99:2002;2613-2618.
28. Tontonoz P., Hu E., Graves R.A., Budavari A.I., Spiegelman B.M. mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev. 8:1994;1224-1234.
29. Xing G., Zhang L., Heynen T., Yoshikawa T., Smith M., Weiss S., Detera-Wadleigh S. Rat PPAR delta contains a CGG triplet repeat and is prominently expressed in the thalamic nuclei. Biochem. Biophys. Res. Commun. 217:1995;1015-1025.